Next Article in Journal
A Systemic Immune Inflammation Index and PD-L1 (SP142) Expression as a Potential Combined Biomarker of the Clinical Benefit of Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer
Next Article in Special Issue
Analysis of Selected Toll-like Receptors in the Pathogenesis and Advancement of Non-Small-Cell Lung Cancer
Previous Article in Journal
Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms
Previous Article in Special Issue
Long-Term Oncologic Outcomes in Robot-Assisted and Video-Assisted Lobectomies for Non-Small Cell Lung Cancer
 
 
Article

Article Versions Notes

J. Clin. Med. 2024, 13(5), 1520; https://doi.org/10.3390/jcm13051520
Action Date Notes Link
article xml file uploaded 6 March 2024 14:44 CET Original file -
article xml uploaded. 6 March 2024 14:44 CET Update https://www.mdpi.com/2077-0383/13/5/1520/xml
article pdf uploaded. 6 March 2024 14:44 CET Version of Record https://www.mdpi.com/2077-0383/13/5/1520/pdf
article supplementary file uploaded. 6 March 2024 14:44 CET - https://www.mdpi.com/2077-0383/13/5/1520#supplementary
article html file updated 6 March 2024 14:45 CET Original file https://www.mdpi.com/2077-0383/13/5/1520/html
Back to TopTop